Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives

Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives

Substantial improvements have characterized the systemic treatment of metastatic colorectal cancer (mCRC) over the past 20 years. Besides strong evidence that supports the use of RAS and BRAF status as prognostic and predictive indicators of disease and response, novel technologies have made possibl...

Full description

Bibliographic Details
Main Authors: Nicola Personeni, Valeria Smiroldo, Emilio Francesco Giunta, Maria Giuseppina Prete, Lorenza Rimassa, Giacomo Bregni, Francesco Sclafani
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
colorectal cancer
metastatic
refractory
molecular characterization
biomarker-driven strategies
targeted agents
Online Access:https://www.mdpi.com/2072-6694/13/18/4506

Internet

https://www.mdpi.com/2072-6694/13/18/4506

Similar Items